Catalog No
IGX-RP1185
Supplier
ImuGeX
Size
1 mg > 10 µg
Product Overview
Product Properties
Target Gene
Product Overview
Product Specifications
| Description | EPO is predominantly synthesized and secreted by tubular and juxtatubular capillary, endothelial, and interstitial cells of the kidney. Approximately 10-15% of the total amount of Epo comes from extrarenal sources and is predominantly produced by hepatocytes and Kupffer cells of the liver. Approximately 40% of the molecular mass of Epo is due to its glycosylation. Glycosylation is an important factor determining the pharmacokinetic behavior of Epo in vivo. Non-glycosylated Epo has an extremely short biological half life. It still binds to its receptor and may even have a higher specific activity in vitro. |
| Purity | >95% as determined by SDS-PAGE |
| Form | Lyophilized from a 0.2 μm filtered solution in PBS (pH 7) |
Product Properties
| Source Antigen | HEK293 |
| Grade | |
| Molecular Weight | 20 |
| Storage Instructions | -70°C |
| Reactivity Life | 6 months |
Target Gene
NA
